Eric Barnes[email protected]25 for 25AuntMinnie 2015: CMS issues final CT lung cancer screening approvalIn 2015, our most popular article reported on the final CMS decision memo for reimbursement of CT lung cancer screening.September 30, 202425 for 25AuntMinnie 2013: NY hospital to shutter radiology residency programOur most highly read article in 2013 reported on a New York City hospital's decision to end its radiology residency program.September 16, 202425 for 25AuntMinnie 2011: Joint Commission issues alert on medical radiationIn 2011, our most highly viewed article reported on a sentinel alert from the Joint Commission on the dangers of medical radiation.September 3, 202425 for 25AuntMinnie 2000: Most imaging devices roll smoothly into Y2KWritten by our late International Editor Eric Barnes, our top article from 2000 was published on January 7 and reported on the aftermath of the Y2K bug.June 17, 2024Page 1 of 1Top StoriesMRIAI model uses MRI data to predict brain cancer patient survivalUsing AI with MRI can help assess outcomes in patients with brain cancer.Womens ImagingUltrafast breast MRI's advantages may need to be reconsideredMolecular ImagingPET/MRI and DECT show abnormalities in long COVID patientsUltrasoundARRS: Cancer status should be considered for axillary breast ultrasoundMRIARRS: Hype is growing around whole-body MRI
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
